Kumquat Biosciences Heterocycle Patent Granted Apr 21
Summary
The USPTO granted patent US12606572B2 to Kumquat Biosciences Inc. on April 21, 2026. The patent covers substituted heterocycle compounds and methods for reducing signaling output of oncogenic proteins. The patent application (19352234) was filed October 7, 2025, and the granted patent contains 20 claims classified under C07D 519/00, A61P 35/00, and A61K 31/553.
What changed
The USPTO issued patent US12606572B2 to Kumquat Biosciences Inc. for substituted heterocycle compounds useful in reducing oncogenic protein signaling output. The patent names Pingda Ren, Baogen Wu, Xiaoming Li, Xiaohui He, and Liansheng Li as inventors. The 20-claim patent covers therapeutic applications in oncology.
For pharmaceutical and biotechnology companies, this patent grant establishes IP protection for heterocycle-based therapeutic compositions. Competitors developing similar compounds targeting oncogenic protein pathways may need to design around this patent or seek licensing arrangements with Kumquat Biosciences.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Substituted heterocycles and uses thereof
Grant US12606572B2 Kind: B2 Apr 21, 2026
Assignee
Kumquat Biosciences Inc.
Inventors
Pingda Ren, Baogen Wu, Xiaoming Li, Xiaohui He, Liansheng Li
Abstract
The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic protein.
CPC Classifications
C07D 519/00 A61P 35/00 A61K 31/553
Filing Date
2025-10-07
Application No.
19352234
Claims
20
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.